Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2 With Proteinuria”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Not applicableUnknownNCT04058951
What this trial is testing

Plant Versus Animal Dietary Protein and the Effect on Proteinuria

Who this might be right for
Kidney InsufficiencyDiabetes MellitusDiabetes Mellitus, Type 2+6 more
Jens Rikardt Andersen 20
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Not applicableStudy completedNCT03889236
What this trial is testing

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Who this might be right for
Diabetic Nephropathy Type 2AlbuminuriaType2 Diabetes Mellitus+7 more
Leiden University Medical Center 56
Post-approval studies (Phase 4)Study completedNCT00136773
What this trial is testing

Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Who this might be right for
Albuminuria
Novartis 332
Not applicableUnknownNCT00655330
What this trial is testing

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Who this might be right for
Type 2 Diabetes MellitusNephropathy
Guangdong Provincial People's Hospital 170
Post-approval studies (Phase 4)UnknownNCT00749047
What this trial is testing

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Who this might be right for
Diabetes Mellitus, Type 2
Christchurch Hospital 12
Post-approval studies (Phase 4)Study completedNCT01028287
What this trial is testing

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Who this might be right for
Diabetic NephropathyNephrotic Syndrome
Southeast Renal Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Testing effectiveness (Phase 2)Study completedNCT00160225
What this trial is testing

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Who this might be right for
Hypertension
Solvay Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01375322
What this trial is testing

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Albuminuria
TSH Biopharm Corporation Limited 226
Not applicableStudy completedNCT00715481
What this trial is testing

Renal Insufficiency And Cardiovascular Events

Who this might be right for
Cardiovascular Disease
Diabetic Nephropathy Study Group 15,628
Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing

Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80
Post-approval studies (Phase 4)Study completedNCT01588795
What this trial is testing

Renal Denervation in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyPersistent Proteinuria With Type II Diabetes
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)Study completedNCT02547935
What this trial is testing

Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Who this might be right for
Type 2 Diabetes Mellitus, CKD and Albuminuria
AstraZeneca 459
Post-approval studies (Phase 4)Study completedNCT03983551
What this trial is testing

Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

Who this might be right for
Type 2 Diabetes MellitusProteinuria
Changhua Christian Hospital 101
Testing effectiveness (Phase 2)Study completedNCT01712061
What this trial is testing

Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathy
Pfizer 226
Testing effectiveness (Phase 2)Study completedNCT01547897
What this trial is testing

NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Type 2 Diabetes MellitusAlbuminuria
TME Pharma AG 76
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Post-approval studies (Phase 4)Ended earlyNCT03029351
What this trial is testing

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesKidney Diseases
University at Buffalo 15
Load More Results